ENOV — Enovis Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Enovis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 76.3 | -11.8 | -32.7 | -825 | -1,184 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 56.2 | -47.8 | 5.29 | 677 | 1,093 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -17.1 | -222 | -27.3 | -13.9 | 15.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 356 | -55.9 | 135 | 114 | 217 |
| Capital Expenditures | -104 | -105 | -122 | -181 | -197 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -216 | -70.9 | -120 | -775 | 18 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -320 | -176 | -242 | -955 | -179 |
| Financing Cash Flow Items | -34.2 | 1,120 | -91.2 | -14.3 | -16.8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 585 | -465 | 128 | 847 | -52.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 618 | -695 | 20.5 | 3.33 | -11.8 |